Rogue antibodies could be driving severe COVID-19
From Nature:
More than a year after COVID-19 emerged, many mysteries persist about the disease: why do some people get so much sicker than others? Why does lung damage sometimes continue to worsen well after the body seems to have cleared the SARS-CoV-2 virus? And what is behind the extended, multi-organ illness that lasts for months in people with long COVID? A growing number of studies suggest that some of these questions might be explained by the immune system mistakenly turning against the body a phenomenon known as autoimmunity.
This is a rapidly evolving area, but all the evidence is converging, says Aaron Ring, an immunologist at the Yale School of Medicine in New Haven, Connecticut.
Early in the pandemic, researchers suggested that some people have an overactive immune response to COVID infection. Immune-system signalling proteins called cytokines can ramp up to dangerous levels, leading to cytokine storms and damage to the bodys own cells. Clinical trials have now shown that some drugs that broadly dampen immune activity seem to reduce death rates in critically ill people, if administered at the right time.
But scientists studying COVID are increasingly also highlighting the role of autoantibodies: rogue antibodies that attack either elements of the bodys immune defences or specific proteins in organs such as the heart. In contrast to cytokine storms, which tend to cause systemic, short-duration problems, autoantibodies are thought to result in targeted, longer-term damage, says immunologist Akiko Iwasaki, a colleague of Rings at Yale.
more ...